BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 12214458)

  • 21. Adverse prognostic factors for testicular cancer-specific survival: a population-based study of 27,948 patients.
    Fosså SD; Cvancarova M; Chen L; Allan AL; Oldenburg J; Peterson DR; Travis LB
    J Clin Oncol; 2011 Mar; 29(8):963-70. PubMed ID: 21300926
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [What is new in 2011 regarding testicular cancer].
    Krege S
    Urologe A; 2011 Sep; 50 Suppl 1():187-91. PubMed ID: 21837493
    [TBL] [Abstract][Full Text] [Related]  

  • 23. ["Second opinion centers". Approach for improving the quality of treatment for testicular tumors].
    Schrader M; Hartmann M; Krege S; Miller K; Weissbach L
    Urologe A; 2006 Apr; 45(4):493-4. PubMed ID: 16489445
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Atypical symptoms in patients with germinal testicular tumors].
    Dieckmann KP; Krain J; Gottschalk W; Büttner P
    Urologe A; 1994 Jul; 33(4):325-30. PubMed ID: 7524231
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Management of testicular seminoma.
    Milosevic MF; Gospodarowicz M; Warde P
    Semin Surg Oncol; 1999 Dec; 17(4):240-9. PubMed ID: 10588852
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Management of Clinical Stage I Testicular Cancer: How Should We Define Success?
    Pagliaro LC; Tannir NM; Tu SM; Logothetis CJ
    J Clin Oncol; 2015 Jul; 33(20):2321-2. PubMed ID: 26033805
    [No Abstract]   [Full Text] [Related]  

  • 27. [Follow-up of testicular germ cell cancer patients: interdisciplinary evidence-based recommendations].
    Hartmann M; Krege S; Souchon R; De Santis M; Gillessen S; Cathomas R;
    Urologe A; 2011 Jul; 50(7):830-5. PubMed ID: 21503662
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Reply to L.C. Pagliaro et al.
    Kollmannsberger CK; Nichols CR
    J Clin Oncol; 2015 Jul; 33(20):2328. PubMed ID: 26033817
    [No Abstract]   [Full Text] [Related]  

  • 29. Reply to L.C. Pagliaro et al.
    Feldman DR
    J Clin Oncol; 2015 Jul; 33(20):2327-8. PubMed ID: 26033811
    [No Abstract]   [Full Text] [Related]  

  • 30. Late relapses (>2 years) in patients with stage I testicular germ cell tumors: predictive factors and survival.
    Fedyanin M; Tryakin A; Kanagavel D; Bulanov A; Burova A; Figurin K; Fainshtein I; Sergeev U; Zakharova T; Garin A; Tjulandin S
    Urol Oncol; 2013 May; 31(4):499-504. PubMed ID: 21803619
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Management of localized germ-cell tumours of the testis].
    Loriot Y; Fizazi K
    Rev Prat; 2007 Feb; 57(4):379-84. PubMed ID: 17455739
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Post treatment follow-up of patients with testicular cancer by primary care physicians].
    Steiner R; Beyer J
    Praxis (Bern 1994); 2014 Jan; 103(3):125-32; quiz 131. PubMed ID: 24468451
    [No Abstract]   [Full Text] [Related]  

  • 33. Assessment of Prognostic Factors of Racial Disparities in Testicular Germ Cell Tumor Survival in the United States (1992-2015).
    Wu J; Ji YB; Tang BW; Brown M; Wang BH; Du CL; Du JS; Wang XM; Cai LJ; Wu GY; Zhou Y
    Biomed Environ Sci; 2021 Feb; 34(2):152-162. PubMed ID: 33685574
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Testicular seminoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.
    Schmoll HJ; Jordan K; Huddart R; Pes MP; Horwich A; Fizazi K; Kataja V;
    Ann Oncol; 2010 May; 21 Suppl 5():v140-6. PubMed ID: 20555065
    [No Abstract]   [Full Text] [Related]  

  • 35. Treatment of a population based sample of men diagnosed with testicular cancer in the United States.
    Osswald M; Harlan LC; Penson D; Stevens JL; Clegg LX
    Urol Oncol; 2009; 27(6):604-10. PubMed ID: 18799329
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Current considerations in the diagnosis and initial treatment of testicular cancer.
    Sagalowsky AI
    Compr Ther; 1994; 20(12):688-94. PubMed ID: 7882652
    [No Abstract]   [Full Text] [Related]  

  • 37. [Value of radiotherapy in interdisciplinary management of testicular germ cell tumors].
    Classen J; Souchon R; Herrmann E; Bamberg M
    Urologe A; 2000 Mar; 39(2):126-32. PubMed ID: 10768222
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Reply to C. Rusner et al, L.C. Pagliaro et al, and K. Lu.
    Daugaard G; Kier MG; Mortensen MS; Agerbæk M; Holm NV; Rørth M; von der Maase H; Jarle Christensen I; Lauritsen J
    J Clin Oncol; 2015 Jul; 33(20):2326-7. PubMed ID: 26033816
    [No Abstract]   [Full Text] [Related]  

  • 39. Testicular seminoma: ESMO clinical recommendations for diagnosis, treatment and follow-up.
    ; Huddart RA
    Ann Oncol; 2007 Apr; 18 Suppl 2():ii40-1. PubMed ID: 17491040
    [No Abstract]   [Full Text] [Related]  

  • 40. Fifteen-year experience of testicular neoplasm in a regional centre.
    Dodds LJ; Murphy D; Neerhut G; Leggatt R
    Aust N Z J Surg; 1997 Dec; 67(12):857-9. PubMed ID: 9451341
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.